REGN, CI, BSX: Which “Strong Buy” Healthcare Stock Is the Best Bet? [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Regeneron Pharmaceuticals, Inc. (REGN)
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.regeneron.com
Company Research
Source: Yahoo! Finance
intrinsic value, the healthcare scene stands out as an intriguing place to bet on. Indeed, rotating cash from scorching-hot winners into some relatively lukewarm winners that are more attractively priced can make a lot of sense. Though I would not give up on tech, I would encourage investors to be more price-selective. You don't need to pay a high-double-digit multiple for exposure to a fast grower, especially if you're willing to embrace the healthcare scene. This piece will use TipRanks' Comparison Tool to go over three healthcare stocks —REGN, CI, BSX—with Strong Buys given by the analyst community. Regeneron (NASDAQ:REGN) Regeneron is an innovative biotech firm with a large market cap ($111.3 billion) and a lofty quadruple-digit share price long overdue for a split. The company has a healthy pipeline of offerings covering various ailments, including inflammation-related diseases, ocular diseases, cancer, and liver disease. Indeed, you're covering many bases with a sizeab
Show less
Read more
Impact Snapshot
Event Time:
REGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
REGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
REGN alerts
High impacting Regeneron Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
REGN
News
- The Schall Law Firm Initiates Probe Into Allegations Against Regeneron Pharmaceuticals Inc And Urges Impacted Investors To Establish CommunicationAccesswire
- Nykode Therapeutics Announces Updates on its Inverse Vaccine Platform at FOCIS 2024 Meeting [Yahoo! Finance]Yahoo! Finance
- The Schall Law Firm Initiates Probe Into Allegations Against Regeneron Pharmaceuticals Inc And Urges Impacted Investors To Reach OutAccesswire
- The Schall Law Firm Begins Investigation Into Claims Against Regeneron Pharmaceuticals Inc And Encourages Affected Investors To ConnectAccesswire
- Axtria Announces its First Ignite Leadership Award Honorees [Yahoo! Finance]Yahoo! Finance
REGN
Earnings
- 5/2/24 - Beat
REGN
Sec Filings
- 6/20/24 - Form 8-K
- 6/17/24 - Form 4
- 6/14/24 - Form 144
- REGN's page on the SEC website